{"id":7666,"date":"2024-05-28T15:52:41","date_gmt":"2024-05-28T19:52:41","guid":{"rendered":"https:\/\/www.conferencecannabis.ca\/?page_id=7666"},"modified":"2024-05-28T15:52:41","modified_gmt":"2024-05-28T19:52:41","slug":"program","status":"publish","type":"page","link":"https:\/\/www.conferencecannabis.ca\/en\/program\/","title":{"rendered":"Program"},"content":{"rendered":"\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\tThe conference will be held in French and English. Simultaneous translation services will be available on site.<\/span>

June 12 & 13<\/h2>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\"\"\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t

PROGRAM<\/h3><\/div>\n \t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t
Presented by:
<\/span>\"\"<\/h6><\/div>\n \t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t
\n
\n
\n
\n
Canadian Cannabis Conference 2024 – Day 1<\/div>\n
12\/06\/2024<\/div>\n <\/div>\n <\/div>\n <\/div>\n
\n
\n
\n
\n\n
\n
\n <\/i><\/span>\n \n 0 h 00 min - 0 h 00 min <\/span>\n <\/div>\n
\n <\/i><\/span><\/span>\n <\/div>\n
\n <\/i><\/span>\n \n By <\/span> Sonia Isabel<\/a> <\/span>\n <\/div>\n <\/div>\n\n
\n

Conference hosted by<\/h3>\n
\n
\n \"\"<\/a>
\n
Sonia Isabel<\/div>\n
Commercial & Operations Leader<\/div>\n <\/div>\n <\/div>\n <\/div>\n
<\/div>\n
<\/i><\/div>\n <\/div>\n <\/div>\n <\/div>\n
\n
\n\n
\n
\n <\/i><\/span>\n \n 0 h 00 min - 0 h 00 min <\/span>\n <\/div>\n
\n <\/i><\/span>Foyer<\/span>\n <\/div>\n <\/div>\n\n
\n

8h00 AM - Networking breakfast and kiosks<\/h3>\n
<\/div>\n <\/div>\n <\/div>\n <\/div>\n
\n
\n\n
\n
\n <\/i><\/span>\n \n 0 h 00 min - 0 h 00 min <\/span>\n <\/div>\n
\n <\/i><\/span>Main room<\/span>\n <\/div>\n <\/div>\n\n
\n

9h00 AM - Opening remarks<\/h3>\n
<\/div>\n <\/div>\n <\/div>\n <\/div>\n
\n
\n\n
\n
\n <\/i><\/span>\n \n 0 h 00 min - 0 h 00 min <\/span>\n <\/div>\n
\n <\/i><\/span>Main room<\/span>\n <\/div>\n
\n <\/i><\/span>\n \n By <\/span> Terence Ndonyi, Bukong, Ph.D<\/a> <\/span>\n <\/div>\n <\/div>\n\n
\n

9h15 AM - Harnessing Cannabis: Unlocking New Frontiers in Liver and Viral Disease Management<\/h3>\n
\n
\n \"\"<\/a>
\n
Terence Ndonyi, Bukong, Ph.D<\/div>\n
Associate Professor at the Centre Armand-Frappier Sant\u00e9 Biotechnologie (INRS)<\/div>\n <\/div>\n <\/div>\n <\/div>\n

The legalization of recreational cannabis use has seen a rapid increase in the use of more and more potent cannabis products. Given that legalization has preceded basic research to understand the health effects of cannabis, we are now in a situation where we do not fully understand the effects of a legalized drug that is readily available to the public.
\nBuilding upon a robust body of epidemiological research, including studies conducted by our team at INRS\u2013Centre Armand-Frappier Sant\u00e9 Biotechnologie, we are advancing the understanding of how cannabis affects liver diseases and viral infections. Our research is increasingly revealing that the beneficial or detrimental effects of cannabis on health conditions like alcoholic liver disease (ALD), non-alcoholic fatty liver disease (NAFLD), and hepatic viral infections may be critically dependent on the specific composition of the cannabis formulation, its dose, and the duration of use.<\/p>\n

Influential studies from our group have demonstrated significant relationships between cannabis use and liver health. For instance, findings suggest that cannabis use is associated with a reduced prevalence of conditions such as steatosis, hepatitis, cirrhosis, and hepatocellular carcinoma, particularly among populations with a history of heavy alcohol use. This research has underscored the potential of cannabis formulation to modulate disease progression through mechanisms that likely involve the endocannabinoid system's interaction with cannabinoid receptors (CBR), known for their role in inflammatory processes and their potential anti-inflammatory properties.<\/p>\n

Our ongoing investigations aim to further delineate these interactions by focusing on how different cannabinoid profiles of full-spectrum recreational cannabis formulations affect the pathophysiology of hepatic and viral infections. This knowledge is critical as cannabis use becomes increasingly prevalent, outpacing the scientific understanding of its implications for liver health and disease management. Our research highlights the therapeutic potential of some full-spectrum cannabis formulations, paving new pathways for the treatment and management of hepatic and viral diseases. By integrating data from in-vitro, in-vivo, and epidemiological studies, our work would contribute significantly to the body of knowledge that informs public health policies and clinical guidelines. Ultimately, we seek to guide safe cannabis use, mitigating risks associated with adverse health consequences and promoting a scientific foundation for developing cannabinoid-based therapies.<\/p>\n<\/div>\n

<\/i><\/div>\n <\/div>\n <\/div>\n <\/div>\n
\n
\n\n
\n
\n <\/i><\/span>\n \n 0 h 00 min - 0 h 00 min <\/span>\n <\/div>\n
\n <\/i><\/span>Main room<\/span>\n <\/div>\n
\n <\/i><\/span>\n \n By <\/span> Dr Davoud Torkamaneh<\/a> <\/span>\n <\/div>\n <\/div>\n\n
\n

9h45 AM - Decoding Cannabis Traits: From Genome to Phenome<\/h3>\n
\n
\n \"\"<\/a>
\n
Dr Davoud Torkamaneh<\/div>\n
Professor Universit\u00e9 Laval<\/div>\n <\/div>\n <\/div>\n <\/div>\n

This seminar explores the intricate genetic landscape of cannabis traits through an integrative approach spanning genomics, phenomics, metabolomics, genome editing, and AI. By deciphering the genetic basis of agronomic, phenological, and metabolic traits, we unravel not only their evolutionary past but also foresee their future trajectories. This knowledge revolutionizes breeding and selection practices, offering targeted interventions for optimized cannabis cultivation. Join us as we delve into the genetic blueprint shaping cannabis diversity.<\/p>\n<\/div>\n

<\/i><\/div>\n <\/div>\n <\/div>\n <\/div>\n
\n
\n\n
\n
\n <\/i><\/span>\n \n 0 h 00 min - 0 h 00 min <\/span>\n <\/div>\n
\n <\/i><\/span>Main room<\/span>\n <\/div>\n
\n <\/i><\/span>\n \n By <\/span> Annabelle Bazire<\/a> <\/span>\n <\/div>\n <\/div>\n\n
\n

10h15 AM - Medical cannabis in France: ambitions and challenges<\/h3>\n
\n
\n \"\"<\/a>
\n
Annabelle Bazire<\/div>\n
General Manager at DelleD - LaFleur<\/div>\n <\/div>\n <\/div>\n <\/div>\n

France is building its own model, inspired by those already in place in many countries around the world. After a look back at the French experiment that ended on March 27, 2024, what lessons have been learned? What regulatory framework is being put in place to provide access to medical cannabis for the patients concerned? We'll be looking at prescribing procedures and pharmaceutical circuit specifications for cannabis-based medicines. A regulatory framework conducive to opening up the market?\"<\/p>\n<\/div>\n

<\/i><\/div>\n <\/div>\n <\/div>\n <\/div>\n
\n
\n\n
\n
\n <\/i><\/span>\n \n 0 h 00 min - 0 h 00 min <\/span>\n <\/div>\n
\n <\/i><\/span>Foyer<\/span>\n <\/div>\n
\n <\/i><\/span>\n \n By <\/span> Bis Solutions<\/a> <\/span>\n <\/div>\n <\/div>\n\n
\n

10h45 AM - Coffee break, networking and kiosks<\/h3>\n
\n
\n \"\"<\/a>
\n
Bis Solutions<\/div>\n
<\/div>\n <\/div>\n <\/div>\n <\/div>\n

Presented by:<\/p>\n<\/div>\n

<\/i><\/div>\n <\/div>\n <\/div>\n <\/div>\n
\n
\n\n
\n
\n <\/i><\/span>\n \n 0 h 00 min - 0 h 00 min <\/span>\n <\/div>\n
\n <\/i><\/span>Main room<\/span>\n <\/div>\n
\n <\/i><\/span>\n \n By <\/span> David Klein<\/a>Philippe Depault<\/a>Jason Moscovici<\/a> <\/span>\n <\/div>\n <\/div>\n\n
\n

11h15 AM - Canada\u2019s leadership in cannabis: a forum for innovative ways to break down barriers<\/h3>\n
\n
\n \"\"<\/a>
\n
David Klein<\/div>\n
Chief Executive Officer (CEO) at Canopy Growth<\/div>\n <\/div>\n <\/div>\n
\n \"\"<\/a>
\n
Philippe Depault<\/div>\n
Founder\/CEO of Qu\u00e9bec Craft and member of ISED<\/div>\n <\/div>\n <\/div>\n
\n \"\"<\/a>
\n
Jason Moscovici<\/div>\n
President, Intellectual Property and Regulatory Affairs Attorney at Provisions Legal Services Inc.<\/div>\n <\/div>\n <\/div>\n <\/div>\n

Innovation, Science and Economic Development Canada (ISDE) Forum Cannabis panel - Moderated by Jason Moscovici \u2013 Provisions Legal Services Inc.<\/p>\n<\/div>\n

<\/i><\/div>\n <\/div>\n <\/div>\n <\/div>\n
\n
\n\n
\n
\n <\/i><\/span>\n \n 0 h 00 min - 0 h 00 min <\/span>\n <\/div>\n
\n <\/i><\/span>Main Room<\/span>\n <\/div>\n
\n <\/i><\/span>\n \n By <\/span> Jean-Maxim LeBrun<\/a>Yanick Tanguay<\/a> <\/span>\n <\/div>\n <\/div>\n\n
\n

11h45 AM - Dunton Rainville: An exclusive partnership to support and develop your business<\/h3>\n
\n
\n \"\"<\/a>
\n
Jean-Maxim LeBrun<\/div>\n
Lawyer at Dunton Rainville<\/div>\n <\/div>\n <\/div>\n
\n \"\"<\/a>
\n
Yanick Tanguay<\/div>\n
Vice-President of Dunton Rainville<\/div>\n <\/div>\n <\/div>\n <\/div>\n
<\/div>\n
<\/i><\/div>\n <\/div>\n <\/div>\n <\/div>\n
\n
\n\n
\n
\n <\/i><\/span>\n \n 0 h 00 min - 0 h 00 min <\/span>\n <\/div>\n
\n <\/i><\/span>Foyer<\/span>\n <\/div>\n
\n <\/i><\/span>\n \n By <\/span> Rose LifeScience<\/a> <\/span>\n <\/div>\n <\/div>\n\n
\n

12h00 PM - Networking lunch and kiosks<\/h3>\n
\n
\n \"\"<\/a>
\n
Rose LifeScience<\/div>\n
<\/div>\n <\/div>\n <\/div>\n <\/div>\n

Presented by:<\/p>\n<\/div>\n

<\/i><\/div>\n <\/div>\n <\/div>\n <\/div>\n
\n
\n\n
\n
\n <\/i><\/span>\n \n 0 h 00 min - 0 h 00 min <\/span>\n <\/div>\n
\n <\/i><\/span>Main room<\/span>\n <\/div>\n
\n <\/i><\/span>\n \n By <\/span> Dr. Hugo Tremblay<\/a> <\/span>\n <\/div>\n <\/div>\n\n
\n

1h20 PM - Cannabis Clinical Research: Challenges and Progress<\/h3>\n
\n
\n \"\"<\/a>
\n
Dr. Hugo Tremblay<\/div>\n
Vice President Operations at PurCann Pharma<\/div>\n <\/div>\n <\/div>\n <\/div>\n

1. Introduction: Background and Importance of Cannabis Clinical Research
\n2. Regulations and the distinction between Recreational, Medical and Pharmaceutical Cannabis
\n3. Types of Clinics and Methodologies Used in Cannabis Research
\n4. Examples of Current Research and Future Areas of Development
\n5. Positioning PurCann Pharma in the Cannabis Clinical Research Sector<\/p>\n<\/div>\n

<\/i><\/div>\n <\/div>\n <\/div>\n <\/div>\n
\n
\n\n
\n
\n <\/i><\/span>\n \n 0 h 00 min - 0 h 00 min <\/span>\n <\/div>\n
\n <\/i><\/span>Main room<\/span>\n <\/div>\n
\n <\/i><\/span>\n \n By <\/span> Lucile Rapin<\/a> <\/span>\n <\/div>\n <\/div>\n\n
\n

1h45 PM - Pain Management<\/h3>\n
\n
\n \"\"<\/a>
\n
Lucile Rapin<\/div>\n
Doctor in Cognitive Science, Sant\u00e9 Cannabis<\/div>\n <\/div>\n <\/div>\n <\/div>\n

Among the treatments for non-cancer chronic pain, cannabinoid-based treatments have become extremely popular. Evidence remains modest and is primarily limited to delta-9-tetrahydrocannabinol (THC) for neuropathic pain; nevertheless, the use of various cannabinoid-based medicines (CBMs), including oral cannabidiol (CBD), to treat neuropathic, nociceptive, and mixed pain has increased worldwide. During clinical evaluation, identifying the pain mechanism can guide the most appropriate management, but cannabinoid-based treatments are rarely considered . This presentation will describe the role cannabinoids can play in managing chronic pain and present the results of an observational study on patients with non-cancer chronic pain.<\/p>\n<\/div>\n

<\/i><\/div>\n <\/div>\n <\/div>\n <\/div>\n
\n
\n\n
\n
\n <\/i><\/span>\n \n 0 h 00 min - 0 h 00 min <\/span>\n <\/div>\n
\n <\/i><\/span>Main room<\/span>\n <\/div>\n
\n <\/i><\/span>\n \n By <\/span> Dr. Jennifer Anderson MD, CCFP<\/a> <\/span>\n <\/div>\n <\/div>\n\n
\n

2h15 PM - From Desperation to Innovation: A Physician's Journey with Medical Cannabis<\/h3>\n
\n
\n \"\"<\/a>
\n
Dr. Jennifer Anderson MD, CCFP<\/div>\n
Family physician specializing in cannabinoids<\/div>\n <\/div>\n <\/div>\n <\/div>\n

Join us for an inspiring keynote presentation as Dr. Anderson shares their deeply personal journey navigating the challenges of managing their son's intractable epilepsy. Faced with the limitations of traditional anti-epileptic treatments, Dr. Anderson embarked on a mission to explore alternative therapies, ultimately pioneering a groundbreaking approach to incorporating cannabinoids into patient care.
\nThrough her consult-based practice, Dr. Anderson integrates cannabinoid medicine into the treatment plans of patients spanning a wide age range and diverse medical conditions, including epilepsy, autism, chronic pain, and anxiety\/depression. From infants to centenarians, Dr. Anderson provides hope and a lifeline to those who have exhausted conventional treatment options.
\nDrawing from her experiences in both hospital and emergency room settings, Dr. Anderson will shed light on the transformative potential of medical cannabis and the critical role it plays in advancing the field of medicine. Prepare to be inspired by a story of resilience, innovation, and compassionate care as Dr. Anderson shares her journey from desperation to innovation in the rapidly evolving realm of medical cannabinoids.<\/p>\n<\/div>\n

<\/i><\/div>\n <\/div>\n <\/div>\n <\/div>\n
\n
\n\n
\n
\n <\/i><\/span>\n \n 0 h 00 min - 0 h 00 min <\/span>\n <\/div>\n
\n <\/i><\/span>Foyer<\/span>\n <\/div>\n
\n <\/i><\/span>\n \n By <\/span> SQDPI – Soci\u00e9t\u00e9 Qu\u00e9b\u00e9coise de D\u00e9veloppement des Plantes Industrielles<\/a> <\/span>\n <\/div>\n <\/div>\n\n
\n

3h00 PM - Coffee break, networking and kiosks<\/h3>\n
\n
\n \"\"<\/a>
\n
SQDPI – Soci\u00e9t\u00e9 Qu\u00e9b\u00e9coise de D\u00e9veloppement des Plantes Industrielles<\/div>\n
<\/div>\n <\/div>\n <\/div>\n <\/div>\n
<\/div>\n
<\/i><\/div>\n <\/div>\n <\/div>\n <\/div>\n
\n
\n\n
\n
\n <\/i><\/span>\n \n 0 h 00 min - 0 h 00 min <\/span>\n <\/div>\n
\n <\/i><\/span>Main room<\/span>\n <\/div>\n
\n <\/i><\/span>\n \n By <\/span> Dr Marcus Delatte<\/a> <\/span>\n <\/div>\n <\/div>\n\n
\n

3h30 PM - Developing cannabis extracts and individual cannabinoids for therapeutic purposes<\/h3>\n
\n
\n \"\"<\/a>
\n
Dr Marcus Delatte<\/div>\n
VP, Regulatory Strategy at Allucent<\/div>\n <\/div>\n <\/div>\n <\/div>\n
<\/div>\n
<\/i><\/div>\n <\/div>\n <\/div>\n <\/div>\n
\n
\n\n
\n
\n <\/i><\/span>\n \n 0 h 00 min - 0 h 00 min <\/span>\n <\/div>\n
\n <\/i><\/span>Main room<\/span>\n <\/div>\n
\n <\/i><\/span>\n \n By <\/span> Dr Owen McMaster<\/a> <\/span>\n <\/div>\n <\/div>\n\n
\n

3h50 PM - Regulatory pathway for cannabidiol products<\/h3>\n
\n
\n \"\"<\/a>
\n
Dr Owen McMaster<\/div>\n
Master Pharmacologist Division of Pharmacology Toxicology for Infectious Diseases Office of New Drugs Center for Drug Evaluation and Research US (FDA)<\/div>\n <\/div>\n <\/div>\n <\/div>\n
<\/div>\n
<\/i><\/div>\n <\/div>\n <\/div>\n <\/div>\n
\n
\n\n
\n
\n <\/i><\/span>\n \n 0 h 00 min - 0 h 00 min <\/span>\n <\/div>\n
\n <\/i><\/span>Main room<\/span>\n <\/div>\n
\n <\/i><\/span>\n \n By <\/span> Dr Owen McMaster<\/a>Jason Moscovici<\/a>Dr Marcus Delatte<\/a> <\/span>\n <\/div>\n <\/div>\n\n
\n

4h10 PM - Discussion moderated by Jason Moscovici \u2013 Provisions Legal Services Inc.<\/h3>\n
\n
\n \"\"<\/a>
\n
Dr Owen McMaster<\/div>\n
Master Pharmacologist Division of Pharmacology Toxicology for Infectious Diseases Office of New Drugs Center for Drug Evaluation and Research US (FDA)<\/div>\n <\/div>\n <\/div>\n
\n \"\"<\/a>
\n
Jason Moscovici<\/div>\n
President, Intellectual Property and Regulatory Affairs Attorney at Provisions Legal Services Inc.<\/div>\n <\/div>\n <\/div>\n
\n \"\"<\/a>
\n
Dr Marcus Delatte<\/div>\n
VP, Regulatory Strategy at Allucent<\/div>\n <\/div>\n <\/div>\n <\/div>\n
<\/div>\n
<\/i><\/div>\n <\/div>\n <\/div>\n <\/div>\n
\n
\n\n
\n
\n <\/i><\/span>\n \n 0 h 00 min - 0 h 00 min <\/span>\n <\/div>\n
\n <\/i><\/span>Main room<\/span>\n <\/div>\n
\n <\/i><\/span>\n \n By <\/span> Pierre Leclerc<\/a>Paul McCarthy<\/a>Tyler Klimas<\/a>Nathan Mison<\/a> <\/span>\n <\/div>\n <\/div>\n\n
\n

4h30 PM - Panel moderated by Nathan Mison - A Cannabis North American Market - Insights into Canada and The United States as New Regulatory Regimes are Developed<\/h3>\n
\n
\n \"\"<\/a>
\n
Pierre Leclerc<\/div>\n
CEO of AQIC and former Chief of Staff to Lucie Charlebois, Quebec Minister of Rehabilitation, Youth Protection, Public Health and Healthy Living<\/div>\n <\/div>\n <\/div>\n
\n \"\"<\/a>
\n
Paul McCarthy<\/div>\n
President of the Cannabis Council of Canada<\/div>\n <\/div>\n <\/div>\n
\n \"\"<\/a>
\n
Tyler Klimas<\/div>\n
Principal\/Founder at Leaf Street Strategies<\/div>\n <\/div>\n <\/div>\n
\n \"\"<\/a>
\n
Nathan Mison<\/div>\n
Founding Partner at Diplomat Consulting<\/div>\n <\/div>\n <\/div>\n <\/div>\n
<\/div>\n
<\/i><\/div>\n <\/div>\n <\/div>\n <\/div>\n
\n
\n\n
\n
\n <\/i><\/span>\n \n <\/span>\n <\/div>\n
\n <\/i><\/span>Foyer<\/span>\n <\/div>\n
\n <\/i><\/span>\n \n By <\/span> Dunton Rainville<\/a> <\/span>\n <\/div>\n <\/div>\n\n
\n

5h15 PM - Conference Cocktail<\/h3>\n
\n
\n \"\"<\/a>
\n
Dunton Rainville<\/div>\n
<\/div>\n <\/div>\n <\/div>\n <\/div>\n
<\/div>\n
<\/i><\/div>\n <\/div>\n <\/div>\n <\/div>\n <\/div>\n <\/div>\n <\/div>\n \t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t
\n
\n
\n
\n
Conf\u00e9rence canadienne sur le cannabis 2024 – Day 2<\/div>\n
13\/06\/2024<\/div>\n <\/div>\n <\/div>\n <\/div>\n
\n
\n
\n
\n\n
\n
\n <\/i><\/span>\n \n 0 h 00 min - 0 h 00 min <\/span>\n <\/div>\n
\n <\/i><\/span><\/span>\n <\/div>\n
\n <\/i><\/span>\n \n By <\/span> Sonia Isabel<\/a> <\/span>\n <\/div>\n <\/div>\n\n
\n

Conference hosted by:<\/h3>\n
\n
\n \"\"<\/a>
\n
Sonia Isabel<\/div>\n
Commercial & Operations Leader<\/div>\n <\/div>\n <\/div>\n <\/div>\n
<\/div>\n
<\/i><\/div>\n <\/div>\n <\/div>\n <\/div>\n
\n
\n\n
\n
\n <\/i><\/span>\n \n 0 h 00 min - 0 h 00 min <\/span>\n <\/div>\n
\n <\/i><\/span>Foyer<\/span>\n <\/div>\n
\n <\/i><\/span>\n \n By <\/span> Nuances Marijuana<\/a> <\/span>\n <\/div>\n <\/div>\n\n
\n

8h00 AM - Networking breakfast and kiosks<\/h3>\n
\n
\n \"\"<\/a>
\n
Nuances Marijuana<\/div>\n
<\/div>\n <\/div>\n <\/div>\n <\/div>\n
<\/div>\n
<\/i><\/div>\n <\/div>\n <\/div>\n <\/div>\n
\n
\n\n
\n
\n <\/i><\/span>\n \n 0 h 00 min - 0 h 00 min <\/span>\n <\/div>\n
\n <\/i><\/span>Main room<\/span>\n <\/div>\n
\n <\/i><\/span>\n \n By <\/span> AQIC<\/a> <\/span>\n <\/div>\n <\/div>\n\n
\n

9h00 AM - AQIC AGM members only<\/h3>\n
\n
\n \"\"<\/a>
\n
AQIC<\/div>\n
Quebec Cannabis Industry Association (AQIC)<\/div>\n <\/div>\n <\/div>\n <\/div>\n

- Financial statements
\n- Achievements
\n- 2025 \u2013 2027 Strategic Plan<\/p>\n<\/div>\n

<\/i><\/div>\n <\/div>\n <\/div>\n <\/div>\n
\n
\n\n
\n
\n <\/i><\/span>\n \n 0 h 00 min - 0 h 00 min <\/span>\n <\/div>\n
\n <\/i><\/span>Main room<\/span>\n <\/div>\n
\n <\/i><\/span>\n \n By <\/span> AQIC<\/a> <\/span>\n <\/div>\n <\/div>\n\n
\n

10h00 AM - AQIC AGM members and CCC participants<\/h3>\n
\n
\n \"\"<\/a>
\n
AQIC<\/div>\n
Quebec Cannabis Industry Association (AQIC)<\/div>\n <\/div>\n <\/div>\n <\/div>\n

Presentation of the Canadian cannabis catalog and of the training tool for Canadian producers and retailers on AQIC web site secured section<\/p>\n<\/div>\n

<\/i><\/div>\n <\/div>\n <\/div>\n <\/div>\n
\n
\n\n
\n
\n <\/i><\/span>\n \n 0 h 00 min - 0 h 00 min <\/span>\n <\/div>\n
\n <\/i><\/span>Foyer<\/span>\n <\/div>\n
\n <\/i><\/span>\n \n By <\/span> Laurentide Injection<\/a> <\/span>\n <\/div>\n <\/div>\n\n
\n

10h45 AM - Coffee break, networking and kiosks<\/h3>\n
\n
\n \"\"<\/a>
\n
Laurentide Injection<\/div>\n
<\/div>\n <\/div>\n <\/div>\n <\/div>\n

Presented by:<\/p>\n<\/div>\n

<\/i><\/div>\n <\/div>\n <\/div>\n <\/div>\n
\n
\n\n
\n
\n <\/i><\/span>\n \n 0 h 00 min - 0 h 00 min <\/span>\n <\/div>\n
\n <\/i><\/span>Main room<\/span>\n <\/div>\n
\n <\/i><\/span>\n \n By <\/span> Gordon Dobrindt<\/a>Dave Terranova<\/a>Sandra McAllister<\/a>Don Haney<\/a>Richard Lapsley<\/a>Steris AST<\/a> <\/span>\n <\/div>\n <\/div>\n\n
\n

11h15 AM - An Overview of Irradiation Effects on Cannabis Processing<\/h3>\n
\n
\n \"\"<\/a>
\n
Gordon Dobrindt<\/div>\n
Director Quality Systems at Steris<\/div>\n <\/div>\n <\/div>\n
\n \"\"<\/a>
\n
Dave Terranova<\/div>\n
Senior Director, Plant Operations at Steris<\/div>\n <\/div>\n <\/div>\n
\n \"\"<\/a>
\n
Sandra McAllister<\/div>\n
Manager, Operations II at Steris<\/div>\n <\/div>\n <\/div>\n
\n \"\"<\/a>
\n
Don Haney<\/div>\n
Plant Manager II at Steris<\/div>\n <\/div>\n <\/div>\n
\n \"\"<\/a>
\n
Richard Lapsley<\/div>\n
Territory Account Manager at Steris<\/div>\n <\/div>\n <\/div>\n
\n \"\"<\/a>
\n
Steris AST<\/div>\n
<\/div>\n <\/div>\n <\/div>\n <\/div>\n

As an agricultural product, cannabis, including its seeds, can be exposed to contamination with pathogenic fungi, bacteria, yeast, and mold during growing, drying, packaging, and delivery, which poses health risks for consumers. Radiation technologies such as gamma and electron beam (E-beam) irradiation are commonly used treatment methods to address many of the safety concerns with cannabis. In this presentation, we will discuss irradiation effects on cannabis including the benefits and risks of not irradiating cannabis products, the similarities and differences of E-beam and gamma processing, exporting product and requirements to the EU, and a brief summary of new irradiation facilities in Canada.<\/p>\n<\/div>\n

<\/i><\/div>\n <\/div>\n <\/div>\n <\/div>\n
\n
\n\n
\n
\n <\/i><\/span>\n \n 0 h 00 min - 0 h 00 min <\/span>\n <\/div>\n
\n <\/i><\/span>Main room<\/span>\n <\/div>\n
\n <\/i><\/span>\n \n By <\/span> Karine Thibault (SQDPI)<\/a> <\/span>\n <\/div>\n <\/div>\n\n
\n

11h30 AM - Supplying Quebec's industrial plant sector: from agriculture to industry<\/h3>\n
\n
\n \"\"<\/a>
\n
Karine Thibault (SQDPI)<\/div>\n
General Manager, Interplantes Strategic Advisor - Ecomaterials Sector, MRC des Sources Collaborator, Soci\u00e9t\u00e9 qu\u00e9b\u00e9coise de d\u00e9veloppement des plantes industrielles<\/div>\n <\/div>\n <\/div>\n <\/div>\n

Let's explore the many potentials of the industrial plant value chain, mainly through cannabis' colleague, industrial hemp. We'll take a look at this ecosystem of innovation and entrepreneurial research and development that has been developing over the last ten years in Quebec with biobased materials. What are the challenges and advances, from the field to 1st and 2nd transformation?<\/p>\n

Industrial plants are plants that are primarily intended for manufacturing processing. They have non-food applications in fields such as construction materials, polymer processing (plastics incorporating biobased fibers), technical textiles, packaging, cosmetics, biofuels, etc.<\/p>\n

Converging interests are emerging, both among manufacturers who want to source eco-responsible, renewable, local and low-carbon materials, and among agricultural producers who want to increase crop rotation potential and diversify their income.<\/p>\n

Our objectives are to increase the sector's economic value by increasing the number of products marketed using bio-sourced materials, to strengthen the supply of industrial plants, and to ensure better consultation and collaboration between the various stakeholders in this value chain in order to rally the strengths and complementarity of networks.<\/p>\n<\/div>\n

<\/i><\/div>\n <\/div>\n <\/div>\n <\/div>\n
\n
\n\n
\n
\n <\/i><\/span>\n \n 0 h 00 min - 0 h 00 min <\/span>\n <\/div>\n
\n <\/i><\/span>Foyer<\/span>\n <\/div>\n
\n <\/i><\/span>\n \n By <\/span> Origine Nature<\/a> <\/span>\n <\/div>\n <\/div>\n\n
\n

12h00 PM - Networking Lunch<\/h3>\n
\n
\n \"\"<\/a>
\n
Origine Nature<\/div>\n
<\/div>\n <\/div>\n <\/div>\n <\/div>\n

Presented by:<\/p>\n<\/div>\n

<\/i><\/div>\n <\/div>\n <\/div>\n <\/div>\n
\n
\n\n
\n
\n <\/i><\/span>\n \n 0 h 00 min - 0 h 00 min <\/span>\n <\/div>\n
\n <\/i><\/span>Main room<\/span>\n <\/div>\n
\n <\/i><\/span>\n \n By <\/span> Michel Boucher<\/a> <\/span>\n <\/div>\n <\/div>\n\n
\n

1h20 PM - GS1's role in the cannabis industry<\/h3>\n
\n
\n \"\"<\/a>
\n
Michel Boucher<\/div>\n
Vice President Community Engagement & Strategic Partnership at GS1 Canada<\/div>\n <\/div>\n <\/div>\n <\/div>\n

Review GS1 Canada's role in the various industries and review what we've accomplished based on the demands of the cannabis industry.<\/p>\n<\/div>\n

<\/i><\/div>\n <\/div>\n <\/div>\n <\/div>\n
\n
\n\n
\n
\n <\/i><\/span>\n \n 0 h 00 min - 0 h 00 min <\/span>\n <\/div>\n
\n <\/i><\/span>Main room<\/span>\n <\/div>\n
\n <\/i><\/span>\n \n By <\/span> Annabelle St-Pierre, M.Sc.<\/a>Nathalie Dub\u00e9<\/a>Alexandre Gauthier<\/a> <\/span>\n <\/div>\n <\/div>\n\n
\n

1h50 PM - Exploring the possibilities of a circular economy for a sustainable, environmentally-friendly cannabis industry<\/h3>\n
\n
\n \"\"<\/a>
\n
Annabelle St-Pierre, M.Sc.<\/div>\n
Researcher at Innofibre<\/div>\n <\/div>\n <\/div>\n
\n \"\"<\/a>
\n
Nathalie Dub\u00e9<\/div>\n
QA Specialist \/ R&D Specialist at Origine Nature<\/div>\n <\/div>\n <\/div>\n
\n \"\"<\/a>
\n
Alexandre Gauthier<\/div>\n
VP R&D - Director of Cultivation at Origine Nature<\/div>\n <\/div>\n <\/div>\n <\/div>\n
<\/div>\n
<\/i><\/div>\n <\/div>\n <\/div>\n <\/div>\n
\n
\n\n
\n
\n <\/i><\/span>\n \n 0 h 00 min - 0 h 00 min <\/span>\n <\/div>\n
\n <\/i><\/span>Foyer<\/span>\n <\/div>\n
\n <\/i><\/span>\n \n By <\/span> Cielo Verde<\/a> <\/span>\n <\/div>\n <\/div>\n\n
\n

2h30 PM - Coffee break, networking and kiosks<\/h3>\n
\n
\n \"\"<\/a>
\n
Cielo Verde<\/div>\n
<\/div>\n <\/div>\n <\/div>\n <\/div>\n

Presented by:<\/p>\n<\/div>\n

<\/i><\/div>\n <\/div>\n <\/div>\n <\/div>\n
\n
\n\n
\n
\n <\/i><\/span>\n \n 0 h 00 min - 0 h 00 min <\/span>\n <\/div>\n
\n <\/i><\/span>Main room<\/span>\n <\/div>\n
\n <\/i><\/span>\n \n By <\/span> \u00c9liane Brunet-Perron<\/a>Alexandre Ouellet<\/a> <\/span>\n <\/div>\n <\/div>\n\n
\n

3h00 PM - How to do business with the SQDC<\/h3>\n
\n
\n \"\"<\/a>
\n
\u00c9liane Brunet-Perron<\/div>\n
Analyst go to market at the SQDC<\/div>\n <\/div>\n <\/div>\n
\n \"\"<\/a>
\n
Alexandre Ouellet<\/div>\n
Director Supply Chain at the SQDC<\/div>\n <\/div>\n <\/div>\n <\/div>\n
<\/div>\n
<\/i><\/div>\n <\/div>\n <\/div>\n <\/div>\n
\n
\n\n
\n
\n <\/i><\/span>\n \n 0 h 00 min - 0 h 00 min <\/span>\n <\/div>\n
\n <\/i><\/span>Main room<\/span>\n <\/div>\n
\n <\/i><\/span>\n \n By <\/span> Keven Rousseau<\/a> <\/span>\n <\/div>\n <\/div>\n\n
\n

3h30 PM - Be an agent of change: how to choose eco-friendly cannabis packaging<\/h3>\n
\n
\n \"\"<\/a>
\n
Keven Rousseau<\/div>\n
Social Responsibility Advisor at the SQDC<\/div>\n <\/div>\n <\/div>\n <\/div>\n
<\/div>\n
<\/i><\/div>\n <\/div>\n <\/div>\n <\/div>\n
\n
\n\n
\n
\n <\/i><\/span>\n \n 0 h 00 min - 0 h 00 min <\/span>\n <\/div>\n
\n <\/i><\/span>Main room<\/span>\n <\/div>\n
\n <\/i><\/span>\n \n By <\/span> Suzanne Bergeron<\/a>Genevi\u00e8ve Giroux<\/a> <\/span>\n <\/div>\n <\/div>\n\n
\n

4h PM - Supplier meeting with the SQDC<\/h3>\n
\n
\n \"\"<\/a>
\n
Suzanne Bergeron<\/div>\n
President and CEO at the SQDC<\/div>\n <\/div>\n <\/div>\n
\n \"\"<\/a>
\n
Genevi\u00e8ve Giroux<\/div>\n
Vice-President Supply Chain and Go to Market<\/div>\n <\/div>\n <\/div>\n <\/div>\n
<\/div>\n
<\/i><\/div>\n <\/div>\n <\/div>\n <\/div>\n
\n
\n\n
\n
\n <\/i><\/span>\n \n <\/span>\n <\/div>\n
\n <\/i><\/span>Foyer<\/span>\n <\/div>\n
\n <\/i><\/span>\n \n By <\/span> Steris AST<\/a> <\/span>\n <\/div>\n <\/div>\n\n
\n

5h15 PM - Conference closing cocktail<\/h3>\n
\n
\n \"\"<\/a>
\n
Steris AST<\/div>\n
<\/div>\n <\/div>\n <\/div>\n <\/div>\n

Presented by:<\/p>\n<\/div>\n

<\/i><\/div>\n <\/div>\n <\/div>\n <\/div>\n <\/div>\n <\/div>\n <\/div>\n \t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t
\n \n \t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t<\/i>\n\t\t\t\t\t\t\t<\/span>\n\t\t\t\t\t\t\t\t\tTICKETS<\/span>\n\t\t\t\t\t<\/span>\n\t\t <\/a>\n <\/div>\n \t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t
***This program is preliminary and subject to change according to participants’ confirmations.***<\/u><\/strong><\/h5>

This event is poised to not only facilitate communications between provincial oversight bodies and wholesale distributors but also to enrich professional networks with cannabis decision makers and licensed producers. The location also provides an unforgettable experience in one of Canada’s most picturesque cities.<\/p>

We eagerly anticipate your presence in Quebec City, where industry synergy and cultural exploration await!<\/p>

\u00a0<\/p><\/div>\n \t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t<\/div>\n\t\t","protected":false},"excerpt":{"rendered":"

The conference will be held in French and English. Simultaneous translation services will be available on site. June 12 & 13 PROGRAM Presented by: Canadian Cannabis Conference 2024 – Day 1 12\/06\/2024 0 h 00 min – 0 h 00 min By Sonia Isabel Conference hosted by Sonia Isabel Commercial & Operations Leader 0 h … Read More “AM conference”<\/span><\/a><\/span><\/p>\n","protected":false},"author":11,"featured_media":4920,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"inline_featured_image":false,"footnotes":""},"class_list":["post-7666","page","type-page","status-publish","has-post-thumbnail","hentry"],"yoast_head":"\n5th Canadian Cannabis Conference in Quebec - May 16th, 2024<\/title>\n<meta name=\"description\" content=\"The cannabis industry 5 years after: What's next? International? \u2013 May 16th 2024 at Hotel Plaza Quebec\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.conferencecannabis.ca\/en\/program\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"2023 Canadian Cannabis Conference in Quebec\" \/>\n<meta property=\"og:description\" content=\"Demystifying cannabinoids: the view of industry experts. May 18th 2023 Conference at Hotel Plaza Quebec\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.conferencecannabis.ca\/en\/program\/\" \/>\n<meta property=\"og:site_name\" content=\"Conf\u00e9rence canadienne sur le cannabis\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/Conf%c3%a9rence-canadienne-sur-le-cannabis-103896734329729\/\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.conferencecannabis.ca\/wp-content\/uploads\/2023\/08\/conference-canadienne-sur-le-cannabis-2023-1200x630-1.png\" \/>\n\t<meta property=\"og:image:width\" content=\"1200\" \/>\n\t<meta property=\"og:image:height\" content=\"630\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:title\" content=\"2023 Canadian Cannabis Conference in Quebec\" \/>\n<meta name=\"twitter:description\" content=\"Demystifying cannabinoids: the view of industry experts. May 18th 2023 Conference at Hotel Plaza Quebec\" \/>\n<meta name=\"twitter:image\" content=\"https:\/\/www.conferencecannabis.ca\/wp-content\/uploads\/2023\/08\/conference-canadienne-sur-le-cannabis-2023-1200x630-1.png\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"16 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.conferencecannabis.ca\/en\/program\/\",\"url\":\"https:\/\/www.conferencecannabis.ca\/en\/program\/\",\"name\":\"5th Canadian Cannabis Conference in Quebec - May 16th, 2024\",\"isPartOf\":{\"@id\":\"https:\/\/www.conferencecannabis.ca\/en\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/www.conferencecannabis.ca\/en\/program\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/www.conferencecannabis.ca\/en\/program\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.conferencecannabis.ca\/wp-content\/uploads\/2023\/02\/vignette-conference-2023-500.jpg\",\"datePublished\":\"2024-05-28T19:52:41+00:00\",\"description\":\"The cannabis industry 5 years after: What's next? International? \u2013 May 16th 2024 at Hotel Plaza Quebec\",\"breadcrumb\":{\"@id\":\"https:\/\/www.conferencecannabis.ca\/en\/program\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.conferencecannabis.ca\/en\/program\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.conferencecannabis.ca\/en\/program\/#primaryimage\",\"url\":\"https:\/\/www.conferencecannabis.ca\/wp-content\/uploads\/2023\/02\/vignette-conference-2023-500.jpg\",\"contentUrl\":\"https:\/\/www.conferencecannabis.ca\/wp-content\/uploads\/2023\/02\/vignette-conference-2023-500.jpg\",\"width\":500,\"height\":500,\"caption\":\"Le 18 mai 2023 \u00e0 l'Hotel Plaza Qu\u00e9bec, le rendez-vous annuel incontournable de l'industrie du cannabis\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.conferencecannabis.ca\/en\/program\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Accueil\",\"item\":\"https:\/\/www.conferencecannabis.ca\/en\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Program\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.conferencecannabis.ca\/en\/#website\",\"url\":\"https:\/\/www.conferencecannabis.ca\/en\/\",\"name\":\"Conf\u00e9rence canadienne sur le cannabis\",\"description\":\"Un \u00e9v\u00e8nement phare sur les derni\u00e8res avanc\u00e9es scientifique en mati\u00e8re de cannabis\",\"publisher\":{\"@id\":\"https:\/\/www.conferencecannabis.ca\/en\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.conferencecannabis.ca\/en\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.conferencecannabis.ca\/en\/#organization\",\"name\":\"Conf\u00e9rence canadienne sur le cannabis\",\"url\":\"https:\/\/www.conferencecannabis.ca\/en\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.conferencecannabis.ca\/en\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.conferencecannabis.ca\/wp-content\/uploads\/2019\/07\/logo-cannabis-couleur-2.svg\",\"contentUrl\":\"https:\/\/www.conferencecannabis.ca\/wp-content\/uploads\/2019\/07\/logo-cannabis-couleur-2.svg\",\"width\":1,\"height\":1,\"caption\":\"Conf\u00e9rence canadienne sur le cannabis\"},\"image\":{\"@id\":\"https:\/\/www.conferencecannabis.ca\/en\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/Conf\u00e9rence-canadienne-sur-le-cannabis-103896734329729\/\"]}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"5th Canadian Cannabis Conference in Quebec - May 16th, 2024","description":"The cannabis industry 5 years after: What's next? International? \u2013 May 16th 2024 at Hotel Plaza Quebec","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.conferencecannabis.ca\/en\/program\/","og_locale":"en_US","og_type":"article","og_title":"2023 Canadian Cannabis Conference in Quebec","og_description":"Demystifying cannabinoids: the view of industry experts. May 18th 2023 Conference at Hotel Plaza Quebec","og_url":"https:\/\/www.conferencecannabis.ca\/en\/program\/","og_site_name":"Conf\u00e9rence canadienne sur le cannabis","article_publisher":"https:\/\/www.facebook.com\/Conf%c3%a9rence-canadienne-sur-le-cannabis-103896734329729\/","og_image":[{"width":1200,"height":630,"url":"https:\/\/www.conferencecannabis.ca\/wp-content\/uploads\/2023\/08\/conference-canadienne-sur-le-cannabis-2023-1200x630-1.png","type":"image\/png"}],"twitter_card":"summary_large_image","twitter_title":"2023 Canadian Cannabis Conference in Quebec","twitter_description":"Demystifying cannabinoids: the view of industry experts. May 18th 2023 Conference at Hotel Plaza Quebec","twitter_image":"https:\/\/www.conferencecannabis.ca\/wp-content\/uploads\/2023\/08\/conference-canadienne-sur-le-cannabis-2023-1200x630-1.png","twitter_misc":{"Est. reading time":"16 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.conferencecannabis.ca\/en\/program\/","url":"https:\/\/www.conferencecannabis.ca\/en\/program\/","name":"5th Canadian Cannabis Conference in Quebec - May 16th, 2024","isPartOf":{"@id":"https:\/\/www.conferencecannabis.ca\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.conferencecannabis.ca\/en\/program\/#primaryimage"},"image":{"@id":"https:\/\/www.conferencecannabis.ca\/en\/program\/#primaryimage"},"thumbnailUrl":"https:\/\/www.conferencecannabis.ca\/wp-content\/uploads\/2023\/02\/vignette-conference-2023-500.jpg","datePublished":"2024-05-28T19:52:41+00:00","description":"The cannabis industry 5 years after: What's next? International? \u2013 May 16th 2024 at Hotel Plaza Quebec","breadcrumb":{"@id":"https:\/\/www.conferencecannabis.ca\/en\/program\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.conferencecannabis.ca\/en\/program\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.conferencecannabis.ca\/en\/program\/#primaryimage","url":"https:\/\/www.conferencecannabis.ca\/wp-content\/uploads\/2023\/02\/vignette-conference-2023-500.jpg","contentUrl":"https:\/\/www.conferencecannabis.ca\/wp-content\/uploads\/2023\/02\/vignette-conference-2023-500.jpg","width":500,"height":500,"caption":"Le 18 mai 2023 \u00e0 l'Hotel Plaza Qu\u00e9bec, le rendez-vous annuel incontournable de l'industrie du cannabis"},{"@type":"BreadcrumbList","@id":"https:\/\/www.conferencecannabis.ca\/en\/program\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Accueil","item":"https:\/\/www.conferencecannabis.ca\/en\/"},{"@type":"ListItem","position":2,"name":"Program"}]},{"@type":"WebSite","@id":"https:\/\/www.conferencecannabis.ca\/en\/#website","url":"https:\/\/www.conferencecannabis.ca\/en\/","name":"Conf\u00e9rence canadienne sur le cannabis","description":"Un \u00e9v\u00e8nement phare sur les derni\u00e8res avanc\u00e9es scientifique en mati\u00e8re de cannabis","publisher":{"@id":"https:\/\/www.conferencecannabis.ca\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.conferencecannabis.ca\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/www.conferencecannabis.ca\/en\/#organization","name":"Conf\u00e9rence canadienne sur le cannabis","url":"https:\/\/www.conferencecannabis.ca\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.conferencecannabis.ca\/en\/#\/schema\/logo\/image\/","url":"https:\/\/www.conferencecannabis.ca\/wp-content\/uploads\/2019\/07\/logo-cannabis-couleur-2.svg","contentUrl":"https:\/\/www.conferencecannabis.ca\/wp-content\/uploads\/2019\/07\/logo-cannabis-couleur-2.svg","width":1,"height":1,"caption":"Conf\u00e9rence canadienne sur le cannabis"},"image":{"@id":"https:\/\/www.conferencecannabis.ca\/en\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/Conf\u00e9rence-canadienne-sur-le-cannabis-103896734329729\/"]}]}},"_links":{"self":[{"href":"https:\/\/www.conferencecannabis.ca\/en\/wp-json\/wp\/v2\/pages\/7666","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.conferencecannabis.ca\/en\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/www.conferencecannabis.ca\/en\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/www.conferencecannabis.ca\/en\/wp-json\/wp\/v2\/users\/11"}],"replies":[{"embeddable":true,"href":"https:\/\/www.conferencecannabis.ca\/en\/wp-json\/wp\/v2\/comments?post=7666"}],"version-history":[{"count":1,"href":"https:\/\/www.conferencecannabis.ca\/en\/wp-json\/wp\/v2\/pages\/7666\/revisions"}],"predecessor-version":[{"id":7668,"href":"https:\/\/www.conferencecannabis.ca\/en\/wp-json\/wp\/v2\/pages\/7666\/revisions\/7668"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.conferencecannabis.ca\/en\/wp-json\/wp\/v2\/media\/4920"}],"wp:attachment":[{"href":"https:\/\/www.conferencecannabis.ca\/en\/wp-json\/wp\/v2\/media?parent=7666"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}